Do HMG-CoA reductase inhibitors improve kidney function? The saga continues

被引：9
作者：
Campese, Vito M. [1 ]
Ku, Elaine [1 ]
Bigazzi, Roberto [1 ]
Bianchi, Stefano [1 ]
机构：
[1] Univ So Calif, Keck Sch Med, Div Nephrol, Los Angeles, CA 90033 USA
来源：
JOURNAL OF NEPHROLOGY | 2011年 / 24卷 / 05期
关键词：
Chronic kidney disease; Proteinuria; Statins; C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; RENAL-FUNCTION; ROSUVASTATIN; ATORVASTATIN; PROGRESSION; DYSLIPIDEMIA; EFFICACY; STATINS; WOMEN;
D O I：
10.5301/jn.5000024
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Several reviews have addressed the role of dyslipidemia in renal injury and the potential renal protective effects of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins). Experimental evidence in animals strongly supports the concept that statins may be renal protective. However, data in humans are scanty and contradictory. A recent controlled study using rosuvastatin has cast some doubts on the renal protective effect of this drug. This article reviews the available evidence pro and con the renal protective effects of statins in human subjects.
引用
收藏
页码：550 / 553
页数：4
相关论文
共 50 条
  • [41] Safety of HMG-CoA Reductase Inhibitors: Focus on Atorvastatin
    Franco Bernini
    Andrea Poli
    Rodolfo Paoletti
    [J]. Cardiovascular Drugs and Therapy, 2001, 15 : 211 - 218
  • [42] Safety of HMG-CoA reductase inhibitors: Focus on atorvastatin
    Bernini, F
    Poli, A
    Paoletti, R
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 2001, 15 (03) : 211 - 218
  • [43] HMG-CoA reductase inhibitors (statins) - A promising approach to stroke prevention
    Hess, DC
    Demchuk, AM
    Brass, LM
    Yatsu, FM
    [J]. NEUROLOGY, 2000, 54 (04) : 790 - 796
  • [44] Effects of HMG-CoA reductase inhibitors on learning and memory in the guinea pig
    Maggo, Simran
    Ashton, John C.
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 723 : 294 - 304
  • [45] Pharmacogenetics and anti-inflammatory effect of HMG-CoA reductase inhibitors
    Rosendo, Alexandre B.
    Dal-Pizzol, Felipe
    Fiegenbaum, Marilu
    de Almeida, Silvana
    [J]. ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2007, 51 (04) : 520 - 525
  • [46] Inflammation, immunity, and HMG-CoA reductase inhibitors -: Statins as antiinflammatory agents?
    Schönbeck, U
    Libby, P
    [J]. CIRCULATION, 2004, 109 (21) : 18 - 26
  • [47] Pityriasis lichenoides chronica Associated with Use of HMG-CoA Reductase Inhibitors
    Massay, R. J. B.
    Maynard, A. A.
    [J]. WEST INDIAN MEDICAL JOURNAL, 2012, 61 (07) : 743 - 745
  • [48] Lowering of elevated ambulatory blood pressure by HMG-CoA reductase inhibitors
    Terzoli, L
    Mircoli, L
    Raco, R
    Ferrari, AU
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2005, 46 (03) : 310 - 315
  • [49] Involvement of agmatine in antidepressant-like effect of HMG-CoA reductase inhibitors in mice
    Rahangdale, Sandip
    Fating, Rajshree
    Gajbhiye, Mona
    Kapse, Mona
    Inamdar, Nazma
    Kotagale, Nandkishor
    Umekar, Milind
    Taksande, Brijesh
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 892
  • [50] HMG-CoA Reductase Inhibitors Bind to PPARα to Upregulate Neurotrophin Expression in the Brain and Improve Memory in Mice
    Roy, Avik
    Jana, Malabendu
    Kundu, Madhuchhanda
    Corbett, Grant T.
    Rangaswamy, Suresh B.
    Mishra, Rama K.
    Luan, Chi-Hao
    Gonzalez, Frank J.
    Pahan, Kalipada
    [J]. CELL METABOLISM, 2015, 22 (02) : 253 - 265
12345